- Goldman Sachs downgraded Citigroup Inc C from Buy to Neutral. The price target for Citigroup has been lowered from $52 to $50. Citigroup shares fell 1.13 percent to $46.55 in pre-market trading.
- JP Morgan downgraded Novavax, Inc. NVAX from Overweight to Neutral. Novavax shares tumbled 85.85 percent to $1.18 in pre-market trading.
- Analysts at Atlantic Equities downgraded Wells Fargo & Co WFC from Neutral to Underweight. Wells Fargo shares dropped 0.41 percent to $45.96 in pre-market trading.
- Cowen & Co. downgraded Horizon Pharma PLC HZNP from Outperform to Market Perform. Horizon Pharma shares declined 0.25 percent to close at $19.58 on Thursday.
- Analysts at Goldman Sachs downgraded McKesson Corporation MCK from Buy to Neutral. The price target for McKesson has been lowered from $210 to $189. McKesson shares fell 0.87 percent to $167.50 in pre-market trading.
- Bank of America downgraded Guidewire Software Inc GWRE from Neutral to Underperform. Guidewire Software shares gained 0.39 percent to close at $61.17 on Thursday.
- Analysts at Bernstein downgraded Twenty-First Century Fox Inc FOXA from Outperform to Market Perform. Twenty-First Century Fox shares declined 1.22 percent to $23.55 in pre-market trading.
- Analysts at Cowen & Co. downgraded Raptor Pharmaceutical Corp. RPTP from Outperform to Market Perform. Raptor Pharmaceutical shares rose 0.22 percent to close at $8.98 on Thursday.
- Citigroup downgraded Novavax, Inc. NVAX from Buy to Neutral. The price target for Novavax has been lowered from $12 to $1.50. Novavax shares fell 85.85 percent to $1.18 in pre-market trading.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
